Flow cytometry DNA applications in pediatric tumor pathology

Pediatric and Developmental Pathology

Volumn 3, Issue 4, 2000, Pages 314-334

  Marshall, Tara ^a,b   Rutledge, Joe C ^a,b  

^a SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cell cycle; DNA ploidy; Flow cytometry; Pediatric neoplasia; Prognosis; Tumor

Indexed keywords

ASTROCYTOMA; CELL CYCLE; CHILDHOOD CANCER; CHOROID PLEXUS TUMOR; DNA CONTENT; DNA DETERMINATION; EPENDYMOMA; EWING SARCOMA; FLOW CYTOMETRY; GLIOMA; HISTIOCYTOSIS X; HISTOGRAM; LEUKEMIA; LYMPHOMA; MEDULLOBLASTOMA; NEPHROBLASTOMA; NEUROBLASTOMA; OSTEOSARCOMA; PLOIDY; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; RHABDOMYOSARCOMA; TISSUE FIXATION;

ADOLESCENT; ASTROCYTOMA; CHILD; CHILD, PRESCHOOL; DNA; FLOW CYTOMETRY; HEPATOBLASTOMA; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA; MEDULLOBLASTOMA; NEOPLASMS; NEUROBLASTOMA; OSTEOSARCOMA; PLOIDIES; PROGNOSIS; TISSUE FIXATION; WILMS TUMOR;

EID: 0033934423     PISSN: 10935266     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100249910047     Document Type: Review

References (87)

1. Jay V, Parkinson D, Becker L, Chan FW. Cell kinetic analysis in pediatric brain and spinal tumors: a study of 117 cases with Ki-67 quantitation and flow cytometry. Pediatr Pathol 1994;14:253-276.
2. Crocker J. The trials and tribulations of interphase Ag-NORs. J Pathol 1995;175:367-368.
3. Hamilton PW, Allen DC. Morphometry in histopathology. J Pathol 1995;175:369-379.
4. Linden MD, el-Naggar AK, Nathanson SD, Jacobson G, Zarbo RJ. Lack of correlation between flow cytometric and immunohistologic proliferation measurements of tumors. Mod Pathol 1996;9:682-689.
5. Zwick D, Morgan R, Pasztor L, Harris D, Hetherington M, Garola R. Comparison between flow cytometric and cytogenetic tumor cell DNA content using a simple flow sample preparation method: ploidy comparison of 86 fresh pediatric tumors. Pediatr Pathol Lab Med 1995;15:845-856.
6. Bauer KD, Duque RE, Shankey TV. Clinical Flow Cytometry: Principles and Application. Baltimore: Williams and Wilkins, 1993.
7. Ross JS. DNA ploidy and cell cycle analysis in cancer diagnosis and prognosis. Oncology 1996;10:867-882, 887-890.
8. Sikora J, Dworacki G, Zeromski J. DNA ploidy, S-phase, and Ki-67 antigen expression in the evaluation of cell content of pleural effusions. Lung 1996;174:303-313.
9. Rew DA. Clinical applications of flow cytometry. Br J Hosp Med 1992;48:171-175.
10. Orfao A, Ruiz-Arguelles A, Lacombe F, Ault K, Basso G, Danova M. Flow cytometry: its applications in hematology. Haematologica 1995;80:69-81.
11. Merkel DE, McGuire WL. Ploidy, proliferative activity and prognosis. DNA flow cytometry of solid tumors. Cancer 1990;65:1194-1205.
12. Jacobsen AB, Fossa SD, Thorud E, Lunde S, Melvik JE, Pettersen EO. DNA flow cytometric values in bladder carcinoma biopsies obtained from fresh and paraffin-embedded material. APMIS 1988;96:25-29.
13. Cross SS, Start RD, Smith JH. Does delay in fixation affect the number of mitotic figures in processed tissue? J Clin Pathol 1990;43:597-599.
14. Donhuijsen K, Schmidt U, Hirche H, van-Beuningen D, Budach V. Changes in mitotic rate and cell cycle fractions caused by delayed fixation. Hum Pathol 1990;21:709-714.
15. Bergers E, Jannink I, van-Diest PI, et al. The influence of fixation delay on mitotic activity and flow cytometric cell cycle variables. Hum Pathol 1997;28:95-100.
16. Becker RL, Mikel UV. Interrelation of formalin fixation, chromatin compactness and DNA values as measured by flow and image cytometry. Anal Quant Cytol Histol 1990; 12:33-41.
17. Wersto RP, Stetler-Stevenson M. Debris compensation of DNA histograms and its effect on S-phase analysis. Cytometry 1995;20:43-52.
18. Collan Y, Klemi P, Kallioniemi OP, Joensuu H, Nordling S, Eskelinen M. Significance of variation in DNA flow cytometry analyses from paraffin-embedded breast cancers. Evaluation of the grading efficiency of ploidy determination, DNA index, and S-phase fraction. Pathol Res Pract 1992;188:581-586.
19. Dressler LG, Seamer LC. Controls, standards, and histogram interpretation in DNA flow cytometry. Methods Cell Biol 1994;41:241-262.
20. Koss LG, Czerniak B, Herz F, Wersto RP. Flow cytometric measurements of DNA and other cell components in human tumors: a critical appraisal. Hum Pathol 1989;20: 528-548.
21. Look AT, Roberson PK, Williams DL, et al. Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia. Blood 1985;65:1079-1086.
22. Trueworthy R, Shuster J, Look T, et al. Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a pediatric oncology group study. J Clin Oncol 1992; 10:606-613.
23. Huh YO, Andreeff M. Flow cytometry. Clinical and research applications in hematologic malignancies. Hematol Oncol Clin North Am 1994;8:703-723.
24. Crocker J, Macartney JC, Smith PJ. Correlation between DNA flow cytometric and nucleolar organizer region data in non-Hodgkin's lymphomas. J Pathol 1988;154:151-156.
25. Christensson B, Lindemalm C, Johansson B, Mellstedt H, Tribukait B, Biberfeld P. Flow cytometric DNA analysis: a prognostic tool in non-Hodgkin's lymphoma. Leukemia Res 1989;13:307-314.
26. Coad NAG, Jones TJ, Muir KR, et al. Analysis of ploidy and proliferative activity in childhood non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD). Pediatr Pathol Lab Med 1997;17:893-902.
27. Stocker JT, Dehner LP. Pediatric Pathology. Philadelphia: Lippincott, 1992.
28. Rabson AR. Flow cytometry in the diagnosis of brain tumors. Neurosurg Clin North Am 1994;5:135-145.
29. Vavruch L, Nordenskjold B, Carstensen J, Enestrom S. Prognostic value of flow cytometry and correlation to some conventional prognostic factors: a retrospective study of archival specimens of 134 astrocytomas. J Neurosurg 1996;85:146-151.
30. Arush BMW, Linn S, Ben-Izhak O, et al. Prognostic significance of DNA ploidy in childhood astrocytomas. Pediatr Hematol Oncol 1999;16:387-396.
31. Reyes-Mugica M, Chou PM, Myint MM, Ridaura-Sanz C, Gonzalez-Crussi F, Tomita T. Ependymomas in children: histologic and DNA-flow cytometric study. Pediatr Pathol 1994;14:453-466.
32. Kotylo PK, Robertson PB, Fineberg NS, Azzarelli B, Jakacki R. Flow cytometric DNA analysis of pediatric intracranial ependymomas. Arch Pathol Lab Med 1997;121: 1255-1258.
33. Yasue M, Tomita T, Engelhard H, Gonzalez-Crussi F, McLone DG, Bauer KD. Prognostic importance of DNA ploidy in medulloblastoma of childhood. J Neurosurg 1989;70:385-391.
34. Gilbertson RJ, Jaros E, Perry RH, Kelly PJ, Lunec J, Pearson ADJ. Mitotic percentage index: a new prognostic factor for childhood medulloblastoma. Eur J Cancer 1997;33: 609-615.
35. Schofield DE, Yunis EJ, Geyer JR, Albright AL, Berger MS, Taylor SR. DNA content and other prognostic features in childhood medulloblastoma. Proposal of a scoring system. Cancer 1992;69:1307-1314.
36. Gajjar AJ, Heideman RL, Douglass EC, et al. Relation of tumor-cell ploidy to survival in children with medulloblastoma. J Clin Oncol 1993;11:2211-2217.
37. Tomita T, Yasue M, Engelhard HH, McLone DG, Gonzalez-Crussi F, Bauer KD. Flow cytometric DNA analysis of medulloblastoma. Prognostic implication of aneuploidy. Cancer 1988;61:744-749.
38. Qualman SJ, Shannon BT, Boesel CP, Jacobs D, Jinkens C, Hayes J. Ploidy analysis and cerebrospinal fluid nephelometry as measures of clinical outcome in childhood choroid plexus neoplasia. Pathol Annu 1992;27:305-321.
39. Coons SW, Johnson PC, Haskett D, Rider R. Flow cytometric analysis of deoxyribonucleic acid ploidy and proliferation in choroid plexus tumors. Neurosurgery 1992; 31:850-856.
40. Centeno BA, Louis DN, Kupsky WJ, Preffer FI, Sobel RA. The AgNOR technique, PCNA immunohistochemistry, and DNA ploidy in the evaluation of choroid plexus biopsy specimens. Am J Clin Pathol 1993;100:690-696.
41. Roland B, Pinto A. Hyperdiploid karyotype in a choroid plexus papilloma. Cancer Genet Cytogenet 1996;90:130-131.
42. Hosokawa Y, Tsuchihashi Y, Okabe H, et al. Pleomorphic xanthoastrocytoma. Ultrastructural, immunohistochemical, and DNA cytofluorometric study of a case. Cancer 1991;68:853-859.
43. Rostomily RC, Hoyt JW, Berger MS, et al. Pleomorphic Xanthoastrocytoma. DNA flow cytometry and outcome analysis of 12 patients. Cancer 1997;80:2141-2150.
44. Taylor SR, Blatt J, Constantino JP, Roederer M, Murphy RF. Flow cytometric DNA analysis of neuroblastoma and ganglioneuroma. A 10-year retrospective study. Cancer 1988;62:749-754.
45. Look AT, Hayes FA, Shuster JJ, et al. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a pediatric oncology group study. J Clin Oncol 1991;9:581-591.
46. Kusafuka T, Fukuzawa M, Oue T, Yoneda A, Okada A, Satani M. DNA flow cytometric analysis of neuroblastoma: distinction of tetraploidy subset. J Pediatr Surg 1994;29: 543-547.
47. Katzenstein HM, Bowman LC, Brodeur GM, et al. Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience - a pediatric oncology group study. J Clin Oncol 1998;16:2007-2017.
48. Brookes CN, Ooms BC, McGill F, England K, Hinchliffe SA, van-Velzen D. Ploidy independence of Ag-NOR number in neuroblastoma. Lab Invest 1992;67:243-245.
49. Huddart SN, Muir KR, Parkes SE, et al. Retrospective study of prognostic values of DNA ploidy and proliferative activity in neuroblastoma. J Clin Pathol 1993;46:1101-1104.
50. Dominici C, Negroni A, Romeo A, et al. Flow cytometric and molecular analysis of proliferative activity and DNA content in neuroblastoma: presence of stationary cells in S-phase. Anticancer Res 1992;12:59-63.
51. Eckschlager T, Pil'at D, Kodet R, et al. DNA ploidy in neuroblastoma. Neoplasma 1996;43:23-26.
52. Douglass EC, Look AT, Webber B, et al. Hyperdiploidy and chromosomal rearrangements define the anaplastic variant of Wilms' tumor. J Clin Oncol 1986;4:975-981.
53. Gururangan S, Dorman A, Ball R, et al. DNA quantitation of Wilms' tumor (nephroblastoma) using flow cytometry and image analysis. J Clin Pathol 1992;45:498-501.
54. Chen F, Li ZC, Ge RQ, Liu GH, Cai W, Zhang ZD. The measurement of DNA content in Wilms' tumor and its clinical significance. J Pediatr Surg 1994;29:548-550.
55. Schmidt D, Wiedemann B, Keil W, Sprenger E, Harms D. Flow cytometric analysis of nephoroblastomas and related neoplasms. Cancer 1986;58:2494-2500.
56. Kumar S, Marsden HB, Cowan RA, Barnes JM. Prognostic relevance of DNA content in childhood renal tumours. Br J Cancer 1989;59:291-295.
57. Yildiz I, Jaffe N, Aksoy F, el-Naggar AK. Regional DNA content heterogeneity in Wilms' tumor: incidence and potential clinical relevance. Anticancer Res 1994;14:1365-1369.
58. O'Meara A, Gururangan S, Ball R, Kay E, Kelsey A. Ploidy changes between diagnosis and relapse in childhood renal tumours. Urol Res 1993;21:345-347.
59. Hayes SJ, Hinchliffe SA, Pope JD, et al. Ploidy analysis on Wilms' tumour touch imprints using ethidium bromide and automated image analysis integrated confocal laser scanning microscopy. Virchows Arch 1995;427:101-104.
60. Barrantes JC, Muir KR, Toyn CE, et al. Thirty-year population-based review of childhood renal tumours with an assessment of prognostic features including tumour DNA characteristics. Med Pediatr Oncol 1993;21:24-30.
61. Hiddemann W, Roessner A, Wormann B, et al. Tumor heterogeneity in osteosarcoma as identified by flow cytometry. Cancer 1987;59:324-328.
62. Bauer HC. DNA cytometry of osteosarcoma. Acta Orthop Scand Suppl 1988;228:1-39.
63. Look AT, Douglass EC, Meyer WH. Clinical importance of near-diploid tumor stem lines in patients with osteosarcoma of an extremity. N Engl J Med 1988;318:1567-1572.
64. Kowal-Vern A, Walloch J, Chou P, et al. Flow and image cytometric DNA analysis in Ewing's sarcoma. Mod Pathol 1992;5:56-60.
65. Dierick AM, Langlois M, Van-Oostveldt P, Roels H. The prognostic significance of the DNA content in Ewing's sarcoma: a retrospective cytophotometric and flow cytometric study. Histopathology 1993;23:333-339.
66. Perotti D, Corletto V, Giardini R, Parafioriti A, Fossati-Bellani F, Luksch R. Retrospective analysis of ploidy in primary osseous and extraosseous Ewing family tumors in children. Tumori 1998;84:493-498.
67. Goldberg NS, Bauer K, Rosen ST, et al. Histiocytosis X. Flow cytometric DNA-content and immunohistochemical and ultrastructural analysis. Arch Dermatol 1986;122: 446-450.
68. Rabkin MS, Wittwer CT, Kjeldsberg CR, Piepkorn MW. Flow-cytometric DNA content of histiocytosis X (Langerhans cell histiocytosis). Am J Pathol 1988;131:283-289.
69. McLelland J, Newton JA, Malone M, Camplejohn RS, Chu AC. A flow cytometric study of Langerhans cell histiocytosis. Br J Dermatol 1989;120:485-491.
70. Ornvold K, Carstensen H, Larsen JK, Christensen IJ, Ralfkiaers E. Flow cytometric DNA analysis of lesions from 18 children with Langerhans cell histiocytosis (histiocytosis X). Am J Pathol 1990;136:1301-1307.
71. Al-Abbadi M, Masih A, Braylan RC, Almasri NM. Soft tissue Langerhans' cell histiocytosis in an adult. A case presentation with flow cytometric analysis and literature review. Arch Pathol Lab Med 1997;121:169-172.
72. Favara BE, Steele A. Langerhans cell histiocytosis of lymph nodes: a morphological assessment of 43 biopsies. Pediatr Pathol Lab Med 1997;17:769-787.
73. Kilpatrick SE, Teot LA, Geisinger KR, et al. Relationship of DNA ploidy to histology and prognosis in rhabdomyosarcoma. Comparison of flow cytometry and image analysis. Cancer 1994;74:3227-3233.
74. Shapiro DN, Parham DM, Douglass EC, et al. Relationship of tumor-cell ploidy to histologic subtype and treatment outcome in children and adolescents with unresectable rhabdomyosarcoma. J Clin Oncol 1991;9:159-166.
75. Niggli FK, Powell JE, Parkes SE, et al. DNA ploidy and proliferative activity (S-phase) in childhood soft-tissue sarcomas: their value as prognostic indicators. Br J Cancer 1994;69:1106-1110.
76. Wijnaendts LC, van-der-Linden JC, van-Diest P, et al. Prognostic importance of DNA flow cytometric variables in rhabdomyosarcomas. J Clin Pathol 1993;46:948-952.
77. De Zen L, Sommaggio A, d'Amore ESG, et al. Clinical relevance of DNA ploidy and proliferative activity in childhood rhabdomyosarcoma: a retrospective analysis of patients enrolled onto the Italian cooperative rhabdomyosarcoma study RMS88. J Clin Oncol 1997;15:1198-1205.
78. Swanson PE, Jaszcz W, Nakhleh RE, Kelly DR, Dehner LP. Peripheral primitive neuroectodermal tumors. A flow cytometric analysis with immunohistochemical and ultrastructural observations. Arch Pathol Lab Med 1992;116: 1202-1208.
79. Brinkhuis M, Wijnaendts LCD, van der Linden JC, et al. Peripheral primitive neruoectodermal tumour and extraosseous Ewing's sarcoma; a histological, immunohistochemical and DNA flow cytometric study. Virchows Arch 1995;425:611-616.
80. Helson L, Traganos F, Ellsworth R, Abramson D. Retinoblastoma and cell cycle cytofluorometric analysis. Arch Ophthalmol 1984;102:616-618.
81. Dangou JM, Salmon I, Torres LFB, et al. DNA histogram typing in retinoblastomas and neuroblastomas. Mod Pathol 1993;6:408-413.
82. Winther J, Ehlers N, Jensen OA, Overgaard J, Prause JU. Predictive value of flow cytometric DNA-analysis on fresh retinoblasoma tissue. Acta Ophthalmol Copenh 1988;66: 217-219.
83. Hata Y, Ishizu H, Ohmori K, et al. Flow cytometric analysis of the nuclear DNA content of hepatoblastoma. Cancer 1991;68:2566-2570.
84. Schmidt D, Wischmeyer P, Leuschner I, et al. DNA analysis in hepatoblastoma by flow and image cytometry. Cancer 1993;72:2914-2919.
85. Rugge M, Sonego F, Pollice L, et al. Hepatoblastoma: DNA nuclear content, proliferative indices, and pathology. Liver 1998;18:128-133.
86. Conran RM, Hitchcock CL, Waclawiw MA, Stocker JT, Ishak KG. Hepatoblastoma: the prognostic significance of histologic type. Pediatr Pathol Lab Med 1992;12:167-183.
87. Zerbini MC, Sredni ST, Grier H, et al. Primary malignant epithelial tumors of the liver in children: a study of DNA content and oncogene expression. Pediatr Dev Pathol 1998;1:270-280.